Product Information
RISPERDAL 4 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $12.3873 per EA under NDC 50458035006. Its NADAC has been published 260 times since Nov 28, 2013.
FDA first approved this application on Dec 29, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458035006
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RISPERIDONEApproval Type
New Drug (NDA)
FDA Application
NDA020272FDA Approved
12/29/1993
TE Code
AB
On Market Since
12/29/1993
Pharmacological Classes
Price Statistics
The NADAC for RISPERDAL 4 MG TABLET has been published 260 times since Nov 28, 2013, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.3873 per EA |
|---|---|
| All-time high | $23.5771 (Jan 11, 2017) |
| All-time low | $12.3463 (Oct 23, 2024) |
| 52-week high | $12.4115 |
| 52-week low | $12.3606 |
| Median price | $19.5207 |
| Average price | $18.0566 |
| Largest weekly change | -47.6% (Oct 23, 2024) |
| Weeks tracked | 260 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RISPERDAL 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RISPERDAL 4 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $12.3873 per EA (NDC 50458035006), effective Aug 19, 2026.
How has the price of RISPERDAL 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for RISPERDAL 4 MG TABLET has declined 30.3%. It has been tracked across 260 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RISPERDAL 4 MG TABLET?
Since Nov 28, 2013, the NADAC for RISPERDAL 4 MG TABLET has ranged from a low of $12.3463 (Oct 23, 2024) to a high of $23.5771 (Jan 11, 2017), with a median of $19.5207 per EA.
Are there cheaper alternatives to RISPERDAL 4 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RISPERIDONE 4 MG TABLET, is $0.0794 per EA — about 99% below RISPERDAL 4 MG TABLET.
Who manufactures RISPERDAL 4 MG TABLET?
RISPERDAL 4 MG TABLET (NDC 50458035006) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.